SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $2,531,730,300 |
| Positions | 92 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $280,920,000 | 1,500,000 |
| INSMED INC | INSM | COM PAR $.01 | $170,592,000 | 1,600,000 |
| CYTOKINETICS INC | CYTK | COM NEW | $136,304,000 | 1,600,000 |
| CVS HEALTH CORP | CVS | COM | $113,795,000 | 1,100,000 |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $81,260,000 | 2,000,000 |
| VERA THERAPEUTICS INC | VERA | CL A | $75,092,500 | 1,750,000 |
| AXSOME THERAPEUTICS INC. | AXSM | COM | $73,431,000 | 300,000 |
| CARDINAL HEALTH INC | CAH | COM | $71,268,000 | 300,000 |
| ROIVANT SCIENCES LTD | ROIV | SHS | $70,780,000 | 2,000,000 |
| RHYTHM PHARMACEUTICALS INC | RYTM | COM | $61,066,500 | 550,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.